| # | Drug | Count |
|---|---|---|
| 0 | MYCOPHENOLATE MOFETIL | 378 |
| 1 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 378 |
| 2 | TACROLIMUS | 377 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 366 |
| 4 | TACROLIMUS OINTMENT 0.1% | 366 |
| 5 | RITUXIMAB | 339 |
| 6 | PREDNISONE | 326 |
| 7 | CYCLOPHOSPHAMIDE | 292 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 292 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 292 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COLLOIDAL OATMEAL 1% | 1 | 0.0714 |
| 1 | FENOPROFEN CALCIUM | 1 | 0.0204 |
| 2 | MEFLOQUINE HYDROCHLORIDE | 3 | 0.0192 |
| 3 | CIDOFOVIR ANHYDROUS | 19 | 0.0131 |
| 4 | L-PHENYLALANINE | 1 | 0.0127 |
| 5 | CARMUSTINE | 36 | 0.0076 |
| 6 | IBRITUMOMAB TIUXETAN | 9 | 0.0059 |
| 7 | BUSULFAN | 93 | 0.0058 |
| 8 | CHLORAMBUCIL | 21 | 0.0053 |
| 9 | BASILIXIMAB | 63 | 0.0053 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 756 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 390 |
| 2 | Alkylating Drug [EPC] | 389 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 195 |
| 4 | Purine Antimetabolite [EPC] | 145 |
| 5 | Calcineurin Inhibitor Immunosuppressant [EPC] | 136 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 113 |
| 7 | Kinase Inhibitor [EPC] | 110 |
| 8 | Topoisomerase Inhibitor [EPC] | 109 |
| 9 | Thalidomide Analog [EPC] | 98 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 38 | 0.0065 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 95 | 0.0049 |
| 2 | Selective T Cell Costimulation Blocker [EPC] | 22 | 0.0046 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 81 | 0.0038 |
| 4 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 61 | 0.0027 |
| 5 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 33 | 0.0024 |
| 6 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 9 | 0.0022 |
| 7 | CCR5 Co-receptor Antagonist [EPC] | 5 | 0.0022 |
| 8 | Alkylating Drug [EPC] | 389 | 0.0016 |
| 9 | Human Immunoglobulin G [EPC] | 32 | 0.0015 |